Kimberly-Clark Corp Dossier
Qualitative Analysis
Business overview
Kimberly-Clark Corporation (NYSE: KMB) is a leading global health and hygiene company founded in 1872 and incorporated in Delaware in 1928. The company is principally engaged in manufacturing and marketing a wide range of essential products made from natural or synthetic fibers using advanced technologies in fibers, nonwovens, and absorbency. Its iconic brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, and WypAll, hold No. 1 or No. 2 market share positions in approximately 70 countries. Following a major portfolio transformation, the company's continuing operations are organized into two primary reportable segments: North America and International Personal Care, focusing on five global daily-need product categories: Baby & Child Care, Adult Care, Feminine Care, Family Care, and Professional.
Research as of 29 Jul 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
A comprehensive organizational restructuring initiated in 2024 to create a more agile, focused enterprise matrix structure. The initiative involves optimizing the company's margin profile, scaling proprietary innovation faster across global markets, and exiting low-margin or non-core businesses (such as the U.S. private label diaper business and the international tissue business).
Expected impact: Aims to generate approximately $200 million of SG&A savings over the next few years, improve long-term margin structure, and accelerate volume-plus-mix led organic growth.
A landmark domestic expansion program centering on two major transformative projects: a new advanced manufacturing facility in Warren, Ohio, and an expansion of the Beech Island, South Carolina site with a state-of-the-art automated distribution center, alongside automation upgrades across the North American supply chain network.
Expected impact: Significantly enhances U.S. manufacturing capacity, accelerates innovation plans, supports long-term growth targets, and is expected to create more than 900 highly skilled jobs in industrial automation and advanced manufacturing.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To create a global health and wellness leader by marrying Kimberly-Clark's blue-chip tissue and baby-care franchise with Kenvue's world-class over-the-counter (OTC) and consumer-health portfolio (including Tylenol, Band-Aid, Listerine, Aveeno, and Neutrogena). The acquisition pivots Kimberly-Clark toward higher-growth, higher-margin personal care categories and reduces cyclicality.
Financial impact: The combined company is projected to generate annual net revenues of approximately $32 billion and approximately $7 billion of adjusted EBITDA (based on 2025 projections). The transaction is expected to deliver annual run-rate synergies of approximately $2.1 billion.
Strategic Partnerships
High. Kimberly-Clark is contributing substantially all the assets of its International Family Care and Professional (IFP) business (which generated $3.3 billion of net sales in 2024) to form a preeminent international tissue and professional products company. Suzano will own 51% and Kimberly-Clark will own 49%. This allows Kimberly-Clark to exit low-margin tissue operations while retaining equity upside and licensing its global brands (Scott, Kleenex, Viva, WypAll, and K-C Professional) to the venture.
Terms: The transaction contemplates an implied current enterprise value for the contributed IFP business of approximately $3.4 billion. Proceeds from the transaction will be held to fund, in part, the cash component of the Kenvue acquisition.